Efficacy and Safety of Fluticasone Propionate Nebulized Suspension for Wheezing Diseases in Infants Aged 0-24 Months

NCT07675252 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Acute Wheezing Disorders in Infants Aged 0 to 24 Months

Interventions

DRUG: Fluticasone Propionate Nebulization
DRUG: Budesonide Nebulization

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]